The global embolic agents market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The liquid embolic agents segment is expected to account for the largest share of the global embolic agents market in terms of value and volume by 2030. Liquid embolic agents are used in occluding bleeding and oncotherapy procedures, which are major applications for this product type. The particulate embolic agent segment is expected to account for the second-largest share of the global embolic agents market in terms of value and volume by 2030. Particulate embolization devices are used in malignant hypertension procedures, which is a major application for this product type. North America accounted for the largest share of the global embolization devices market in terms of value and volume by 2030 due to high prevalence rates among patients with cancerous tumors or other diseases that require treatment with these products as well as high adoption rates among physicians who use these products during surgical procedures such as tumor removal or organ transplantation surgeries.
- The global embolic agents market is expected to grow at a CAGR of 4.5% from 2017 to 2025.
- The increasing prevalence of cardiovascular diseases and the growing number of patients with peripheral vascular disease are the major factors driving the growth of this market over the forecast period.
- Increasing awareness about embolic agents among physicians and patients is also expected to fuel demand for these products in the near future.
- Technological advancements in embolic agent manufacturing processes are anticipated to provide significant opportunities for growth in this market over the next few years as they help manufacturers produce more cost-effective products with improved efficacy and safety profiles that can be used for various applications such as carotid artery stenting, cerebral aneurysm coiling, endovascular repair of abdominal aortic aneurysms (EVAR), etc, thereby increasing their adoption rates among physicians globally.
Industry Growth Insights published a new data on “Embolic Agents Market”. The research report is titled “Embolic Agents Market research by Types (Liquid Embolic Agents, Particulate Embolic Agents, Others), By Applications (Occlude Bleeding, Oncotherapy, Malignant Hypertension, Others), By Players/Companies Medtronic, Terumo, Boston Scientific, Merit Medical, Johnson & Johnson, GEM Italy, IMBiotechnologies Ltd (IMB), Emboflu, BTG, Cook Medical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Embolic Agents Market Research Report
By Type
Liquid Embolic Agents, Particulate Embolic Agents, Others
By Application
Occlude Bleeding, Oncotherapy, Malignant Hypertension, Others
By Companies
Medtronic, Terumo, Boston Scientific, Merit Medical, Johnson & Johnson, GEM Italy, IMBiotechnologies Ltd (IMB), Emboflu, BTG, Cook Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Embolic Agents Market Report Segments:
The global Embolic Agents market is segmented on the basis of:
Types
Liquid Embolic Agents, Particulate Embolic Agents, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Occlude Bleeding, Oncotherapy, Malignant Hypertension, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Terumo
- Boston Scientific
- Merit Medical
- Johnson & Johnson
- GEM Italy
- IMBiotechnologies Ltd (IMB)
- Emboflu
- BTG
- Cook Medical
Highlights of The Embolic Agents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Liquid Embolic Agents
- Particulate Embolic Agents
- Others
- By Application:
- Occlude Bleeding
- Oncotherapy
- Malignant Hypertension
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Embolic Agents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Embolic agents are materials that can travel through the blood and other body tissues to reach a distant organ. They may cause serious health problems if they lodge in an important part of the body, such as the heart or brain.
Some of the major companies in the embolic agents market are Medtronic, Terumo, Boston Scientific, Merit Medical, Johnson & Johnson, GEM Italy, IMBiotechnologies Ltd (IMB), Emboflu, BTG, Cook Medical.
The embolic agents market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Embolic Agents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Embolic Agents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Embolic Agents Market - Supply Chain
4.5. Global Embolic Agents Market Forecast
4.5.1. Embolic Agents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Embolic Agents Market Size (000 Units) and Y-o-Y Growth
4.5.3. Embolic Agents Market Absolute $ Opportunity
5. Global Embolic Agents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Embolic Agents Market Size and Volume Forecast by Type
5.3.1. Liquid Embolic Agents
5.3.2. Particulate Embolic Agents
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Embolic Agents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Embolic Agents Market Size and Volume Forecast by Application
6.3.1. Occlude Bleeding
6.3.2. Oncotherapy
6.3.3. Malignant Hypertension
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Embolic Agents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Embolic Agents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Embolic Agents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Embolic Agents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Embolic Agents Demand Share Forecast, 2019-2026
9. North America Embolic Agents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Embolic Agents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Embolic Agents Market Size and Volume Forecast by Application
9.4.1. Occlude Bleeding
9.4.2. Oncotherapy
9.4.3. Malignant Hypertension
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Embolic Agents Market Size and Volume Forecast by Type
9.7.1. Liquid Embolic Agents
9.7.2. Particulate Embolic Agents
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Embolic Agents Demand Share Forecast, 2019-2026
10. Latin America Embolic Agents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Embolic Agents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Embolic Agents Market Size and Volume Forecast by Application
10.4.1. Occlude Bleeding
10.4.2. Oncotherapy
10.4.3. Malignant Hypertension
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Embolic Agents Market Size and Volume Forecast by Type
10.7.1. Liquid Embolic Agents
10.7.2. Particulate Embolic Agents
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Embolic Agents Demand Share Forecast, 2019-2026
11. Europe Embolic Agents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Embolic Agents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Embolic Agents Market Size and Volume Forecast by Application
11.4.1. Occlude Bleeding
11.4.2. Oncotherapy
11.4.3. Malignant Hypertension
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Embolic Agents Market Size and Volume Forecast by Type
11.7.1. Liquid Embolic Agents
11.7.2. Particulate Embolic Agents
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Embolic Agents Demand Share, 2019-2026
12. Asia Pacific Embolic Agents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Embolic Agents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Embolic Agents Market Size and Volume Forecast by Application
12.4.1. Occlude Bleeding
12.4.2. Oncotherapy
12.4.3. Malignant Hypertension
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Embolic Agents Market Size and Volume Forecast by Type
12.7.1. Liquid Embolic Agents
12.7.2. Particulate Embolic Agents
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Embolic Agents Demand Share, 2019-2026
13. Middle East & Africa Embolic Agents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Embolic Agents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Embolic Agents Market Size and Volume Forecast by Application
13.4.1. Occlude Bleeding
13.4.2. Oncotherapy
13.4.3. Malignant Hypertension
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Embolic Agents Market Size and Volume Forecast by Type
13.7.1. Liquid Embolic Agents
13.7.2. Particulate Embolic Agents
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Embolic Agents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Embolic Agents Market: Market Share Analysis
14.2. Embolic Agents Distributors and Customers
14.3. Embolic Agents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Terumo
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boston Scientific
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merit Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Johnson & Johnson
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GEM Italy
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. IMBiotechnologies Ltd (IMB)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Emboflu
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. BTG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Cook Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
